Citation APA
Fontana, M., Berk, J. L., Gillmore, J. J., Witteles, R. M., Grogan, M., Drachman, B., Damy, T., Garcia-Pavia, P., Taubel, J., Solomon, S. D., Sheikh, F. F., Tahara, N., González-Costello, J., Tsujita, K., Morbach, C., Pozsonyi, Z., Petrie, M. C., Delgado, D., Van der Meer, P., Jabbour, A., Bondue, A., Kim, D., Azevedo, O., Hvitfeldt Poulsen, S., Yilmaz, A., Jankowska, E. A., Algalarrondo, V., Slugg, A., Garg, P. P., Boyle, K. L., Yureneva, E., Silliman, N., Yang, L., Chen, J., Eraly, S. S., Vest, J., Maurer, M. S., & HELIOS-B Trial Investigators, (2024). Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy. The New England journal of medicine. doi:10.1056/NEJMoa2409134
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/378785